2244716-55-8
2244716-55-8
Chemical Structure
Lipid 29
- CAS No.: 2244716-55-8
- Formula:C52H97N3O6
- Molecular Weight:860.34
IUPAC Name: heptadecan-9-yl 8-((3-((2-(methylamino)-3,4-dioxocyclobut-1-en-1-yl)amino)propyl)(8-oxo-8-(undecan-3-yloxy)octyl)amino)octanoate
InChIKey: BADFTFAWFNGVTD-UHFFFAOYSA-N
SMILES: O=C1C(C(NCCCN(CCCCCCCC(OC(CCCCCCCC)CCCCCCCC)=O)CCCCCCCC(OC(CCCCCCCC)CC)=O)=C1NC)=O
Biological Activity: Lipid 29 is an ionizable amino lipid. Lipid 29 can be used to form lipid nanoparticles[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Lipid 29 | 99.95% | Lipid 29 is an ionizable amino lipid. Lipid 29 can be used to form lipid nanoparticles. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
SM-102 | 99.97% | SM-102 is an amino cationic lipid useful in the formation of lipid nanoparticles (LNPs). SM-102 has higher transfection efficiency. SM-102 plays an important role in the effectiveness of lipid nanoparticles (LNPs) in delivering mRNA therapeutics and vaccines. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Lipid 5 | 99.91% | Lipid 5 is an amino lipid that affords efficient mRNA delivery in rodent and primate models. Lipid 5 shows optimal pharmacokinetics and non-toxic side effects. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
1-Octylnonyl 8-[[8-[(1-ethylnonyl)oxy]-8-oxooctyl](2-hydroxyethyl)amino]octanoate | 1-Octylnonyl 8-[[8-[(1-ethylnonyl)oxy]-8-oxooctyl](2-hydroxyethyl)amino]octanoate is a PEG lipid. 1-Octylnonyl 8-[[8-[(1-ethylnonyl)oxy]-8-oxooctyl](2-hydroxyethyl)amino]octanoate can be used for researching drug delivery. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Heptadecan-9-yl 8-((6-(decyloxy)-6-oxohexyl)(2-hydroxyethyl)amino)octanoate | Heptadecan-9-yl 8-((6-(decyloxy)-6-oxohexyl)(2-hydroxyethyl) amino) octanoate is an ionizable lipid that can be used in liposome delivery systems for the delivery of mRNA vaccines. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
LNP Lipid-1 | LNP Lipid-1 (Method B) is a lipid compound. LNP Lipid-1 is involved in the synthesis of lipid nanoparticles compositions. LNP Lipid-1 has potential applications in the transport of biologically active substances such as small molecule agents, proteins, and nucleic acids. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Lipid 11 | Lipid 11 (Compound Lipid 1) is a cationic lipid for nucleic acid delivery. Lipid 11 forms lipid nanoparticles (LNPs) through electrostatic binding with nucleic acids (such as ceDNA). Lipid 11 forms complexes with negatively charged nucleic acids via cationic amine groups, which can be endocytosed by cells to release nucleic acids for activity. Lipid 11 is promising for research of gene therapy drug delivery systems. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
LNP Lipid-182 | LNP Lipid-182 can be employed in the development of lipid nanoparticles (LNPs). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
LNP Lipid-48 | 97.0% | LNP Lipid-48 is an SM-102 analog used in the formation of lipid nanoparticles (LNPs). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
E12LA6B6O3 | E12LA6B6O3 is an amino lipid that can be used to prepare nanoparticles for drug delivery, such as mRNA. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Lipid ND-O1 | Lipid ND-O1 is an ether-containing ionizable cationic lipid pKa of 6.6. Lipid ND-O1 can be used to generate lipid nanoparticles (LNPs) for siRNA delivery in vitro and in vivo. Lipid ND-O1 LNPs can be studied in research on hepatic fibrosis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
